The Joint Blog

FEBRUARY 24, 2021

Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s? In a 2004 survey by the Prague Movement Disorder Centre, 25% of 339 respondents had tried a form of cannabis-based treatment. This is not the first medicinal trial of its kind.

Treatment 55

Treatment Clinical Trials Collective Patients 55

The Cannigma

OCTOBER 8, 2021

The UK government made the decision i n 2004 to reclassify cannabis from a Class B to Class C drug, but the decision was rescinded in 2009. During the trip, MP for North Norfolk Sir Norman Lamb famously took cannabis oil on camera, saying that it helps him relax and sleep. What British law permits for medical patients.

Legalization 52

Legalization Medicine Conditions Patients 52

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Epilepsy or epilepsies were mentioned in 39% of articles. Conclusions. Palliative care indications. Cancer pain.

Research and Development 52

Research and Development Medicine Access Media 52

Greencamp

AUGUST 16, 2018

The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.

Strains 94

Strains Cannabinoids Research and Development Indica 94